Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pathology & Lab Medicine

According to CBS News, a vaccine for the deadly Ebola virus may be ready for medical trials in Africa as early as January 2015. Dr. Marie Paule Kieny, WHO assistant director general said clinical trials are planned or underway in Africa, Europe, and the...
NewLink Genetics and Roche have teamed up to develop NewLink’s cancer immunothereapy in a $1 billion deal, Reuters reports. The NewLink inhibitor, NLG919, works to disrupt the process through which tumors elude a patient’s immune system....
An experimental T-Cell therapy which genetically programs a patient’s cells to fight disease is showing promise in bringing remission to leukemia patients, The New York Times reports. According to a study published in The New England Journal of...